Revisão Revisado por pares

Drugs and the developing central nervous system

1980; Elsevier BV; Volume: 11; Issue: 3 Linguagem: Inglês

10.1016/0163-7258(80)90043-1

ISSN

1879-016X

Autores

Antonia Vernadakis,

Tópico(s)

Neonatal and fetal brain pathology

Resumo

In this article, information available on the pharmokinetics of psychotropic medications during pregnancy are reviewed. As many women require psychotropic medication in pregnancy, the course of illness during pregnancy and the risk of teratogenecity of each class of medications are covered. The dilemma of the risks ot discontinuing psychotropic medications in pregnancy versus the potential risk of teratogenecity are discussed.

Referência(s)